Immuneering adds Grant C. Bogle to board as Class III director effective Nov 9, 2026

Immuneering Corp

Board of Immuneering Corporation appointed Grant C. Bogle, MBA, as a Class III director on November 9, 2026.
Bogle has not been appointed to any board committee at this time.
Bogle will be compensated per the company's standard non-employee director arrangements and signed the standard director/officer indemnification agreement.
No arrangement or understanding existed pursuant to which Bogle was elected as a director.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.